Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine

Abstract EN

Drug repositioning is one of the most rapidly emerging fields of study.

This concept is anchored on the principle that diseases have similar damaged or affected signaling pathways.

Recently, drugs have been repositioned not only for their alternative therapeutic uses but also for their applications as biomaterials in various fields.

However, medical drugs as biomaterials are rarely focused on in reviews.

Fragmin and protamine have been recently the sources of increasing attention in the field of tissue engineering and regenerative medicine.

Fragmin and protamine have been manufactured primarily as a safe antidote for the circulating heparin.

Lately, these drugs have been utilized as either micro- or nanoparticle biomaterials.

In this paper, we will briefly describe the concept of drug repositioning and some of the medical drugs that have been repurposed for their alternative therapeutic uses.

Also, this will feature the historical background of the studies focused on fragmin/protamine micro/nanoparticles (F/P M/NPs) and their applications as biomaterials in tissue engineering, stem cell therapy, and regenerative medicine.